Artificial Intelligence for Combating Antimicrobial Resistance: Recent Advances in Prediction, Surveillance, Drug Discovery, Antimicrobial Stewardship and Precision Therapy
Objective: To review the role of artificial intelligence (AI) in addressing antimicrobial resistance (AMR), with a focus on its applications in antimicrobial resistance prediction, surveillance, antimicrobial drug discovery, and personalized antimicrobial therapy. Data Sources: A comprehensive literature search was conducted using electronic databases, including PubMed, Scopus, Google Scholar, and Web of Science, to identify relevant peer-reviewed articles on AI-driven approaches to AMR management. The search primarily covered publications from 2018 to 2026, supplemented by landmark studies and international reports published before 2018 to provide essential background information. Study Selection: Relevant peer-reviewed studies investigating the application of artificial intelligence, machine learning, and deep learning in AMR prediction, surveillance, drug discovery, and personalized antimicrobial therapy were selected. Studies were critically assessed for their relevance to the objectives of the review and their contribution to understanding the potential and limitations of AI-based AMR management. Summary of Content: Antimicrobial resistance is a major global public health challenge that reduces the effectiveness of antimicrobial therapy and contributes to increased morbidity, mortality, and healthcare costs. AI-driven approaches have demonstrated considerable potential in predicting antimicrobial resistance using genomic and clinical data, strengthening AMR surveillance, accelerating antimicrobial drug discovery, and supporting personalized treatment decisions. Unlike previous reviews focusing on individual AI applications, this review presents an integrated multidisciplinary perspective on AI-based AMR management. It also highlights key challenges, including data quality, model interpretability, generalizability, and the need for rigorous clinical validation before widespread implementation. Conclusion: Artificial intelligence offers promising opportunities to improve antimicrobial resistance prediction, surveillance, drug discovery, and personalized antimicrobial therapy. Integrating AI into antimicrobial stewardship and clinical decision-making may contribute to more effective AMR management. However, further validation, high-quality data, interpretable models, and prospective clinical studies are essential to establish the reliability, safety, and practical applicability of these approaches. Keywords: Artificial intelligence; antimicrobial resistance; machine learning; antimicrobial stewardship; deep learning; precision therapy
Authors
- Pooja Bagdi (ORCID: https://orcid.org/0009-0006-5716-3320)
Publication Details
- Journal
- Journal of Drug Delivery and Therapeutics
- Published
- 2026-11-15
- DOI
- https://doi.org/10.22270/jddt.v16i11.8081
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00